LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced that, based on preliminary financial projections, the Company reiterates its previously announced 2008 year-end revenue guidance. On March 11, 2008, Columbia indicated that it expects to achieve 2008 revenues in the range of $35 to $40 million.
